12:00 AM
Mar 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Spiros beclomethasone: Began Phase II/III trial

Dura Pharmaceuticals Inc. (DURA), San Diego, Calif.
Product: Spiros beclomethasone, anti-inflammatory corticosteroid
Indication: Asthma

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >